Amendment: SEC Form SCHEDULE 13D/A filed by Kennedy-Wilson Holdings Inc.

The disclosure in Item 4 of the Existing Schedule 13D is hereby amended and supplemented by deleting the second to last paragraph thereof and adding the following at the end thereof: "Amendment to Merger Agreement On March 15, 2026, Kennedy-Wilson, Parent and Merger Sub entered into an Amendment (the "Merger Agreement Amendment") to the Agreement and Plan of Merger, dated as of February 16, 2026, by and among Kennedy-Wilson, Parent and Merger Sub (the "Original Merger Agreement", and as amended, supplemented and otherwise modified by the Merger Agreement Amendment, the "Merger Agreement"). Pursuant to the Merger Agreement, Merger Sub will be merged with and into Kennedy-Wilson (the "Merger"). The Merger Agreement Amendment amends the Original Merger Agreement to require, as a condition to the completion of the Merger, and in accordance with Section 203(a)(3) of the Delaware General Corporation Law (the "DGCL"), the affirmative vote of at least two-thirds of the outstanding voting power of the (i) Shares of Kennedy-Wilson, (ii) Series A Preferred Stock (on an as-converted basis), (iii) Series B Preferred Stock (based on the number of Series B Warrants outstanding and in accordance with the certificate of designations) and (iv) Series C Preferred Stock (based on the number of Series C Warrants outstanding and in accordance with the certificate of designations), entitled to vote on the proposal to adopt the Merger Agreement (the securities described in clauses (i)-(iv), collectively, the "Voting Stock"), excluding the Voting Stock "owned" (as such term is defined in Section 203 of the DGCL) by the Voting and Support Parties and each of their respective "affiliates" and "associates" (as such terms are defined in Section 203 of the DGCL). Other than as described in this Item 4, and except as otherwise disclosed herein or in agreements described in this Schedule 13D, the Reporting Persons have no present plans or proposals that would relate to or result in any of the matters set forth in subparagraphs (a)-(j) of the instructions to Item 4 of this Statement on Schedule 13D. However, as part of the ongoing evaluation of the transactions contemplated by the Merger Agreement and other agreements described herein, the Reporting Persons may at any time review or reconsider their respective positions with respect to Kennedy-Wilson and formulate plans or proposals with respect to any of such matters and, from time to time, may hold discussions with or make formal proposals to management or Kennedy-Wilson's board of directors, other stockholders of Kennedy-Wilson or other third parties regarding such matters. There can be no assurance that the possible courses of action expressed in this Item 4 will be consummated by the Reporting Persons. The foregoing description of the Merger Agreement Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement Amendment, a copy of which is filed herewith as Exhibit 99.43, and is incorporated herein by reference.

Item 6 of the Existing Schedule 13D is hereby amended and supplemented by the addition of the following: Item 4 references the Merger Agreement Amendment, the description of which is incorporated herein by reference. A copy of the Merger Agreement Amendment is attached as 99.43 to this Schedule 13D, and is incorporated herein by reference.

Item 7 of the Existing Schedule 13D is hereby amended and supplemented by the addition of the following Exhibits: Ex. 99.39: Joint Filing Agreement by and among the Reporting Persons, dated as of March 17, 2026. Ex. 99.40: Power of Attorney, dated March 9, 2020 (incorporated by reference to Exhibit 8 to the Schedule 13D filed by certain of the Reporting Persons with the SEC on March 9, 2020). Ex. 99.41: Power of Attorney, dated April 27, 2021 (incorporated by reference to Exhibit 4 to the Schedule 13D filed by certain of the Reporting Persons with the SEC on June 14, 2021). Ex. 99.42: Power of Attorney, dated June 21, 2023 (incorporated by reference to Exhibit 99.18 to the Schedule 13D filed by certain of the Reporting Persons with the SEC on November 15, 2023). Ex. 99.43: Amendment to the Agreement and Plan of Merger, dated March 15, 2026, by and among Parent, Merger Sub and Kennedy-Wilson (incorporated by reference to Exhibit 2.1 to Kennedy-Wilson's Current Report on Form 8-K, filed with the SEC on March 16, 2026).